Wuhan Union Hospital, China clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 229 studies whose lead sponsor is Wuhan Union Hospital, China. 103 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 6, 2025.
Keep track of what changes. Save the Wuhan Union Hospital, China studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- China
- 189
Focus areas
Conditions Wuhan Union Hospital, China leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 229. Browse all 229 →
- Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies)Not yet recruitingNCT07007767Phase 2
- Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)RecruitingNCT06922851Not applicable
- Clinical Application of PET Imaging Targeting Nectin-4 in Malignant TumorsNot yet recruitingNCT06994078Not applicable
- The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical TrialRecruitingNCT06228794
- Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast CancerRecruitingNCT06367088Phase 2
- A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain MetastasesNot yet recruitingNCT06975462Phase 2
- SHR-A1811 and THPy in First or Second Line for HER2 Positive Advanced Breast Cancer Brain MetastasesNot yet recruitingNCT06975475Phase 2
- Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular CarcinomaRecruitingNCT06383520Early Phase 1
- An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus ErythematosusNot yet recruitingNCT06945068Phase 1
- Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple MyelomaRecruitingNCT06140966Phase 2
- Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated CardiomyopathyRecruitingNCT06741995
- A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal MetastasisRecruitingNCT06685887Phase 2
- Clinical Study of Desuzumab in the Treatment of Knee OsteoarthritisRecruitingNCT06357741
- CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus ErythematosusRecruitingNCT06349343Phase 1
- UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid LeukemiaRecruitingNCT06245746Phase 1
- (Withdrawal) AI-Based Low-Dose 3D-DSA ReconstructionNot yet recruitingNCT06769867Not applicable
- Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational StudyRecruitingNCT06791889
- AI-guided TIPS ProcedureNot yet recruitingNCT06837974Not applicable
- AI-based Low Dose CBCT Reconstruction for Clinical ApplicationNot yet recruitingNCT06831617Not applicable
- Application of 18F-CP6A PET Imaging in SynucleinopathiesNot yet recruitingNCT06827821Early Phase 1
- A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal CancerRecruitingNCT06717880Phase 1
- Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic SyndromeEnrolling by invitationNCT05674539Phase 3
- Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal CancerRecruitingNCT06802666Phase 2
- Effects of Low Tidal Volume and Airway Pressure Release Ventilation on Lung Tissue Mechanics in ARDS Patients Under Mechanical Ventilation: A Prospective Randomized Crossover StudyRecruitingNCT06790875Not applicable
- Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid FailureNot yet recruitingNCT06790888Not applicable
- Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITPRecruitingNCT06686927Phase 2
- The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step TrialRecruitingNCT06785571Phase 2/3
- Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach(Radiogenomics-Lung)RecruitingNCT06500312
- A Clinical Study of CD19 CAR-T in Active Systemic Lupus ErythematosusRecruitingNCT06106906Phase 1/2
- Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARCRecruitingNCT06542588Phase 2
- CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic TumorsRecruitingNCT06735495Phase 1/2
- RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell MalignanciesRecruitingNCT06732492Phase 1
- The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous CarcinomaEnrolling by invitationNCT06647836
- CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic TumorsRecruitingNCT06720324Phase 1/2
- An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's LymphomaRecruitingNCT06693973Early Phase 1
- Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and TreatmentRecruitingNCT06653478
- Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung AdenocarcinomaRecruitingNCT05830812
- Screening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age PatientEnrolling by invitationNCT06591442
- Endovascular Treatment for Stroke Post 1 Day (24 Hours)Not yet recruitingNCT06580730Not applicable
- Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related OutcomesRecruitingNCT06154707Phase 3
- AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06537011Phase 2
- Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach(Radiogenomics-Urinary)RecruitingNCT06537037
- Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach(Radiogenomics-Liver)RecruitingNCT06536998
- Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCTRecruitingNCT06241274Not applicable
- Blood Cell RNA-Based Cancer DetectionRecruitingNCT05839834
- Molecular Study and Precision Medicine for Colorectal CancerNot yet recruitingNCT05883683
- CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsRecruitingNCT06503094Phase 1/2
- Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMMRecruitingNCT06503107Phase 1/2
- Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic CancerRecruitingNCT06491472Phase 2
- The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System TumorsRecruitingNCT06490211